Paxman AB (PAX.ST) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · Sweden · ISIN SE0009806284

Price
68.40 SEK
Market cap
1.51 bn SEK
P/E (2025)
–
P/S (2025)
4.81
Dividend yield
0.00 %
Net margin
-5.33 %
Return on equity (ROE)
-4.13 %
Return on assets (ROA)
-3.49 %

Paxman AB financials

Fiscal year20242025
Revenue253.01 m SEK313.35 m SEK
Gross profit175.42 m SEK208.81 m SEK
Operating income33.51 m SEK4.26 m SEK
EBIT33.51 m SEK4.26 m SEK
Net income40.20 m SEK-16.72 m SEK
Diluted EPS – continuing operations2.11 SEK-0.76 SEK

Full history since 2016, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Paxman AB

Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized form of scalp cooling for the prevention of chemotherapy-induced alopecia. It also engages in the development of a medical cryocompression device for the prevention of chemotherapy-induced peripheral neuropathy. The company was founded in 1996 and is based in Karlshamn, Sweden.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.